Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ProMetic Life Sciences Inc

+ Add to Watchlist

PLI:CN

2.6000 CAD 0.0500 1.89%

As of 16:00:00 ET on 03/06/2015.

Snapshot for ProMetic Life Sciences Inc (PLI)

Open: 2.6200 Day's Range: 2.5600 - 2.6500 Volume: 2,728,926
Previous Close: 2.6500 52wk Range: 0.8500 - 2.7000 1-Yr Rtn: +63.52%

Stock Chart for PLI

No chart data available.
  • PLI:CN 2.6000
  • 1D
  • 1M
  • 1Y
2.6500
Interactive PLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PLI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.0300
Est. EPS (CAD) (12/2014) -0.0030
Est. PEG Ratio -
Market Cap (M CAD) 1,416.60
Shares Outstanding (M) 551.21
30 Day Average Volume 2,716,505
Price/Book (mrq) 46.2675
Price/Sale (ttm) 76.6442
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PLI

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PLI

ProMetic Life Sciences, Inc. is an international bio-pharmaceutical company. The Company, through its subsidiaries, researches, develops, manufactures and markets a variety of commercial applications from its core technology. ProMetic's applications are used in therapeutics, large-scale drug purification, chemical genomics and proteomics, drug delivery and drug development.

Pierre LaurinPresident/CEO/FounderBruce PritchardCFO/Interim COO
John MoranChief Medical OfficerFrederic DumaisDir:Communications & Investor Relations
More Company Profile & Key Executives for PLI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil